Quick Takeaways
- TCG Crossover GP II, LLC filed SCHEDULE 13G for LB Pharmaceuticals Inc. Common Stock, par value $0.0001 per share.
- Disclosed ownership: 7.8%.
- Date of event: 12 Sep 2025.
TCG Crossover GP II, LLC - 12 Sep 2025 SCHEDULE 13G Report for LB Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
- Filing Manager
- TCG Crossover GP II, LLC
- Reporting Manager
- TCG Crossover GP II, LLC
- Shares outstanding
- 22,371,987 shares
- Disclosed Ownership
- 1,745,015 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Sep 2025, 16:24:26 UTC
- Date of event
- 12 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP II, LLC disclosed 7.8% ownership in LB Pharmaceuticals Inc. Common Stock, par value $0.0001 per share on 12 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Sep 2025, 16:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 7.8% | 1,745,015 | 0 | 1,745,015 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund II, L.P. | 7.8% | 1,745,015 | 0 | 1,745,015 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| Chen Yu | 7.8% | 1,745,015 | 0 | 1,745,015 | /s/ Craig Skaling | Craig Skaling, as Attorney-in-Fact for Chen Yu |